Figure 2. Patients with high-risk cytogenetics have a poor prognosis: (A) patients with del(17p), t(4;14), t(14;16)
and t(14;20) cytogenetic abnormalities;22 (B) patients with and without chromosome 1q gains (33% versus 67% of
patients).23 (A) Reprinted by permission from Macmillan Publishers Ltd: Leukemia.22 Copyright 2014. (B) Reprinted
with permission. © 2012 American Society of Clinical Oncology. All rights reserved
Figure 2. Patients with high-risk cytogenetics have a poor prognosis: (A) patients with del(17p), t(4;14), t(14;16)
and t(14;20) cytogenetic abnormalities;22 (B) patients with and without chromosome 1q gains (33% versus 67% of
patients).23 (A) Reprinted by permission from Macmillan Publishers Ltd: Leukemia.22 Copyright 2014. (B) Reprinted
with permission. © 2012 American Society of Clinical Oncology. All rights reserved